| Product NDC: | 63323-405 |
| Proprietary Name: | Clonidine Hydrochloride |
| Non Proprietary Name: | CLONIDINE HYDROCHLORIDE |
| Active Ingredient(s): | 100 ug/mL & nbsp; CLONIDINE HYDROCHLORIDE |
| Administration Route(s): | EPIDURAL |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 63323-405 |
| Labeler Name: | APP Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA200673 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110708 |
| Package NDC: | 63323-405-10 |
| Package Description: | 1 VIAL in 1 CARTON (63323-405-10) > 10 mL in 1 VIAL |
| NDC Code | 63323-405-10 |
| Proprietary Name | Clonidine Hydrochloride |
| Package Description | 1 VIAL in 1 CARTON (63323-405-10) > 10 mL in 1 VIAL |
| Product NDC | 63323-405 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CLONIDINE HYDROCHLORIDE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | EPIDURAL |
| Start Marketing Date | 20110708 |
| Marketing Category Name | ANDA |
| Labeler Name | APP Pharmaceuticals, LLC |
| Substance Name | CLONIDINE HYDROCHLORIDE |
| Strength Number | 100 |
| Strength Unit | ug/mL |
| Pharmaceutical Classes | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] |